Early, validated signal
We surface physician-validated, commercialization-ready cardiovascular companies early — often before they are broadly known.
NuPulse surfaces physician-validated, commercialization-ready companies early — with the clinical evidence acquirers actually use to act.
We surface physician-validated, commercialization-ready cardiovascular companies early — often before they are broadly known.
The clinical data and KOL conviction the major cardiovascular strategics actually use to act.
NuPulse selectively partners with strategic industry leaders to help identify, build, and commercialize technologies aligned with future market needs.
A single, physician-led relationship into a national network and a curated cardiovascular pipeline.
Shape what gets built and share in the value you help create.
More than capital: physician validation, repositioning, and a path to strategic value.
SPV syndication into deals already clinically validated and positioned.
An external innovation radar surfacing physician-validated companies.
Founders, investors, physicians, and strategic partners in cardiovascular and electrophysiology medtech — we would welcome a conversation.
Get in touch →Miami, Florida